Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?

Shares of Zydus Lifesciences jumped more than 7% on Wednesday to hit a fresh 52-week high of Rs 1,091 apiece on the NSE after the pharma company reported a 9% year-on-year (YoY) increase in consolidated net profit to Rs 1,272.5 crore for th
Read more...